Taro Fujii

Taro Fujii

Auto-generated profile, based on publicly available information

Taro Fujii

McGowan Institute for Regenerative Medicine University of Pittsburgh Pittsburgh PA 15219 USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2024 in Advanced Healthcare Materials
Verified
Journal Article
Open access
YHYasunari Hayashi
Yasunari Hayashi
TFTaro Fujii
Taro Fujii
Seungil KimSeungil Kim
Seungil Kim
TOTakahiro Ozeki
Takahiro Ozeki
SBStephen Badylak
Stephen Badylak
WWWilliam R. Wagner
William R. Wagner
Multiple hydrogels are developed for injection therapy after myocardial infarction, with some incorporating substances promoting tissue regeneration and others emphasizing mechanical effects. In this study, porosity and extracellular matrix‐derived digest (ECM) are incorporated, into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N‐isopropylacrylamide‐co‐N‐vinylpyrrolidone‐co‐MAPLA)) and evaluate whether this biomaterial injectate can abrogate adverse remodeling in rat ischemic cardiomyopathy. After myocardial infarction, rats are divided into four groups: NP (non‐porous hydrogel) without either ECM or porosity, PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and PME with porosity and ECM digest added to the synthetic copolymer. PBS injection alone is a control group. Intramyocardial injections occurred 3 days after myocardial infarction followed by serial echocardiography and histological assessments 8 weeks after infarction. Echocardiographic function and neovascularization improved in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated improved LV geometry and macrophage polarization (toward M2) compared to PBS, whereas differences are not observed in the NP or PM groups versus control. These results demonstrate further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing combined mechanical and biological effects.

17 February 2026 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
YTYoshiyuki Tokuda
Yoshiyuki Tokuda
MYMasao Yamada
Masao Yamada
TUTomonari Uemura
Tomonari Uemura
TFTaro Fujii
Taro Fujii
YHYasunari Hayashi
Yasunari Hayashi
MMMasato Mutsuga
Masato Mutsuga
Objectives: Revascularization of the left subclavian artery (LSCA) is routinely required during total aortic arch replacement. In situ reconstruction may be technically difficult in cases with large aneurysms or posterior vessel displacement. Extra-anatomic aorto-axillary bypass has been proposed as an alternative, but its long-term patency relative to in situ repair remains uncertain. This study compared LSCA patency between the 2 techniques. Methods: We retrospectively analysed 436 consecutive patients (median age 69.0 years [interquartile range (IQR) 62.0-75.0]; 347 men) who underwent total arch replacement with LSCA revascularization: 240 in situ and 196 extra-anatomic. Postoperative CT imaging (1853 scans; median 3 [IQR 1-6] per patient) was reviewed to determine immediate and long-term patency. Kaplan-Meier analysis was used for time-to-event comparison. A small descriptive subgroup of 18 patients undergoing concomitant left internal thoracic artery (LITA) to left anterior descending artery (LAD) bypass was also reviewed. Results: Perioperative outcomes, including mortality and major complications, were similar between groups. Subclavian wound infection occurred in 3 extra-anatomic cases (1.5%), all managed successfully with local care. Immediate LSCA patency was higher after extra-anatomic bypass (100% vs 92.9%, P < .001). At 5 years, patency remained superior with extra-anatomic bypass (97.7% vs 87.8%; log-rank P = .0002). In the descriptive LITA-LAD subgroup, CT follow-up demonstrated 100% LSCA and LITA graft patency; however, interpretation is limited by the small sample size. Conclusions: Compared with in situ reconstruction, extra-anatomic LSCA bypass provides equivalent perioperative safety and superior long-term patency. These findings support extra-anatomic bypass as a reliable and technically straightforward option for LSCA revascularization during total arch replacement.

4 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
YHYasunari Hayashi
Yasunari Hayashi
TFTaro Fujii
Taro Fujii
Seungil KimSeungil Kim
Seungil Kim
SBStephen Badylak
Stephen Badylak
ADAntonio D’amore
Antonio D’amore
WWWilliam R. Wagner
William R. Wagner
A variety of hydrogels have been developed for intramyocardial injection therapy after myocardial infarction. Some of these biomaterials have incorporated bioactive substances that promote local tissue regeneration and integration, while others have emphasized the mechanical role of the injectate in providing functional benefit. In this study, we incorporated two bioactive features, porosity, and extracellular matrix derived hydrogel (ECM), into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N-isopropylacrylamide-co-N-vinylpyrrolidone-co-MAPLA) copolymer) and evaluated whether injection of this biomaterial could abrogate the remodeling process in a rat ischemic cardiomyopathy model. After myocardial infarction by coronary artery ligation, rats were randomly divided into four groups: group NP (non-porous hydrogel) without either ECM or porosity, group PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and group PME with porosity and ECM digest added to the synthetic copolymer. A group with PBS injection alone served as a control. Intramyocardial injections were made 3 days after myocardial infarction. Serial echocardiography was assessed over time, and histological assessments were performed eight weeks after infarction. Results demonstrated improved echocardiographic function and neovascularization in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated significant improvement in LV geometry and macrophage polarization (towards M2) compared to the PBS group, whereas these differences were not observed in the NP or PM groups versus the control. These results demonstrate that further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing a combination of mechanical and biological effects.

5 August 2022 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
TFTaro Fujii
Taro Fujii
MMMasato Mutsuga
Masato Mutsuga
YNYuji Narita
Yuji Narita
YTYoshiyuki Tokuda
Yoshiyuki Tokuda
STSachie Terazawa
Sachie Terazawa
AUAkihiko Usui
Akihiko Usui
A 73-year-old man presented with multiple giant coronary artery aneurysms. Twelve years prior to the presentation, he had undergone coronary artery bypass grafting. At that time, he exhibited small aneurysms (16 mm diameter) in the right coronary artery and a single aneurysm (10 mm diameter) in the left circumflex artery. During follow-up, the aneurysms gradually increased in size (to 45 and 30 mm, respectively, at 12 years after surgery). We resected all of the aneurysms and performed coronary artery bypass grafting of the left circumflex artery through re-sternotomy.

10 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MBMarianna Barbuto
Marianna Barbuto
AAArianna Adamo
Arianna Adamo
BCBeatrice di Caccamo
Beatrice di Caccamo
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
TFTaro Fujii
Taro Fujii
ADAntonio D&Apos;Amore
Antonio D&Apos;Amore
Small-diameter vascular grafts remain a major unmet clinical need due to their susceptibility to thrombosis, intimal hyperplasia, and poor long-term patency. Here, we introduce a biomimetic three-layered vascular graft (3LVG) designed to recapitulate the functional heterogeneity of native arteries through a structural gradient that guides host cell infiltration and vascular remodeling. The graft integrates an electrospun poly(carbonate-urethane) urea (PCUU) layer, a bioactive decellularized extracellular matrix medial layer, and a porous thermally induced phase separation PCUU layer. The combination of these techniques produced layers with different pore size ranges to preferentially promote either adventitial-derived (ACR) or intimal-derived (ICR) cell recruitment. Implanted as abdominal aortic interposition grafts in rats, ACR grafts showed superior in vivo performance, with 100% patency at 4 and 8 weeks, whereas ICR grafts demonstrated reduced patency associated with anastomotic intimal hyperplasia. ACR grafts also exhibited enhanced endothelialization, greater adventitial cell infiltration, increased collagen deposition, more abundant vasa vasorum formation, and compliance comparable to native vessels at 8 weeks. These findings demonstrate that bioinspired structural heterogeneity can direct host remodeling, reduce maladaptive luminal responses, and improve graft performance. This work identifies structural gradient-driven cell recruitment as a promising design principle for next-generation small-diameter tissue-engineered vascular grafts.